162 related articles for article (PubMed ID: 8695808)
1. Apoptosis of Burkitt's lymphoma cells induced by specific interaction of surface IgM with a self-antigen: implications for lymphomagenesis in acquired immunodeficiency syndrome.
Roncella S; Cutrona G; Favre A; Ulivi M; Fais F; Signorini A; Grossi CE; Chiorazzi N; Ferrarini M
Blood; 1996 Jul; 88(2):599-608. PubMed ID: 8695808
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous p53 mutations in a Burkitt lymphoma from an AIDS patient with monoclonal c-myc and VDJ rearrangements.
Campomenosi P; Fronza G; Ottaggio L; Roncella S; Inga A; Bogliolo M; Monti P; Assereto P; Moro F; Cutrona G; Bozzo S; Chiorazzi N; Abbondandolo A; Ferrarini M
Int J Cancer; 1997 Dec; 73(6):816-21. PubMed ID: 9399658
[TBL] [Abstract][Full Text] [Related]
3. Identification of HSP-60 as the specific antigen of IgM produced by BRG-lymphoma cells.
Musante L; Ulivi M; Cutrona G; Chiorazzi N; Roncella S; Candiano G; Ferrarini M
Electrophoresis; 1999; 20(4-5):1092-7. PubMed ID: 10344290
[TBL] [Abstract][Full Text] [Related]
4. Two acquired immunodeficiency syndrome-associated Burkitt's lymphomas produce specific anti-i IgM cold agglutinins using somatically mutated VH4-21 segments.
Riboldi P; Gaidano G; Schettino EW; Steger TG; Knowles DM; Dalla-Favera R; Casali P
Blood; 1994 May; 83(10):2952-61. PubMed ID: 8180391
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody with anti-Burkitt lymphoma specificity. I. Analysis of human haematopoietic and lymphoid cell lines.
Wiels J; Lenoir GM; Fellous M; Lipinski M; Salomon JC; Tetaud C; Tursz T
Int J Cancer; 1982 Jun; 29(6):653-8. PubMed ID: 6286514
[TBL] [Abstract][Full Text] [Related]
6. High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: a preventive mechanism of malignant tumor cells against complement attack?
Hofman P; Hsi BL; Manie S; Fenichel P; Thyss A; Rossi B
Breast Cancer Res Treat; 1994; 32(2):213-9. PubMed ID: 7532466
[TBL] [Abstract][Full Text] [Related]
7. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
[TBL] [Abstract][Full Text] [Related]
8. IgMs produced by two acquired immune deficiency syndrome lymphoma cell lines: Ig binding specificity and VH-gene putative somatic mutation analysis.
Ng VL; Hurt MH; Fein CL; Khayam-Bashi F; Marsh J; Nunes WM; McPhaul LW; Feigal E; Nelson P; Herndier BG
Blood; 1994 Feb; 83(4):1067-78. PubMed ID: 8111047
[TBL] [Abstract][Full Text] [Related]
9. A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma.
Jain R; Roncella S; Hashimoto S; Carbone A; Francia di Celle P; Foa R; Ferrarini M; Chiorazzi N
J Immunol; 1994 Jul; 153(1):45-52. PubMed ID: 8207254
[TBL] [Abstract][Full Text] [Related]
10. T cells can induce somatic mutation in B cell receptor-engaged BL2 Burkitt's lymphoma cells independently of CD40-CD40 ligand interactions.
Denépoux S; Fournier N; Péronne C; Banchereau J; Lebecque S
J Immunol; 2000 Feb; 164(3):1306-13. PubMed ID: 10640744
[TBL] [Abstract][Full Text] [Related]
11. Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells.
Chang CH; Wang Y; Gupta P; Goldenberg DM
MAbs; 2015; 7(1):199-211. PubMed ID: 25484043
[TBL] [Abstract][Full Text] [Related]
12. A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death.
Lens SM; Tesselaar K; den Drijver BF; van Oers MH; van Lier RA
J Immunol; 1996 Jan; 156(2):507-14. PubMed ID: 8543800
[TBL] [Abstract][Full Text] [Related]
13. CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells.
Schattner EJ; Mascarenhas J; Bishop J; Yoo DH; Chadburn A; Crow MK; Friedman SM
Blood; 1996 Aug; 88(4):1375-82. PubMed ID: 8695856
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Fas-mediated apoptosis by antigen: implications for lymphomagenesis.
Schattner EJ; Friedman SM; Casali P
Autoimmunity; 2002 Jul; 35(4):283-9. PubMed ID: 12482198
[TBL] [Abstract][Full Text] [Related]
15. Antibody-induced antigenic modulation is antigen dependent: characterization of 22 proteins on a malignant human B cell line.
Pesando JM; Hoffman P; Abed M
J Immunol; 1986 Dec; 137(11):3689-95. PubMed ID: 3491146
[TBL] [Abstract][Full Text] [Related]
16. Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts.
Cutrona G; Ulivi M; Fais F; Roncella S; Ferrarini M
J Exp Med; 1995 Feb; 181(2):699-711. PubMed ID: 7836923
[TBL] [Abstract][Full Text] [Related]
17. Malignant human B cells express two populations of p24 surface antigens.
Pesando JM; Hoffman P; Conrad T
J Immunol; 1986 Apr; 136(7):2709-14. PubMed ID: 3485154
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta 1 cooperates with anti-immunoglobulin for the induction of apoptosis in group I (biopsy-like) Burkitt lymphoma cell lines.
MacDonald I; Wang H; Grand R; Armitage RJ; Fanslow WC; Gregory CD; Gordon J
Blood; 1996 Feb; 87(3):1147-54. PubMed ID: 8562941
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of a new human Burkitt's lymphoma cell line (WSU-BL).
Mohamed AN; Mohammad RM; Koop BF; al-Katib A
Cancer; 1989 Sep; 64(5):1041-8. PubMed ID: 2527086
[TBL] [Abstract][Full Text] [Related]
20. Characterization and distribution in human tissues of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D.
Pancino G; Charpin C; Osinaga E; Betaille B; Le Roy M; Calvo F; Roseto A
Cancer Res; 1990 Nov; 50(22):7333-42. PubMed ID: 2224861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
